SCHEMBL2650890

SCHEMBL2650890

COc1ccccc1C(=O)c1cc(C)ccc1NC(=O)N(c1ncc(CN(C)C)s1)N(C(=O)Nc1ncc(CN2CCNCC2)s1)c1ccc(C)cc1C(=O)c1ccccc1OC

nearest known ligand 0.41

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
OGA O60502 12/20 0.39
SMN1; SMN2 Q16637 2/20 0.35
HTT P42858 1/20 0.35
CHRM3 P20309 1/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK1 P28482 1/20 0.34
ACKR3 P25106 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2650893 0.88 OGA (0.43) POLBOGASMN1; SMN2HTTCHRM3
SCHEMBL6695257 0.82 OGA (0.47) POLBOGASMN1; SMN2HTTCHRM3
SCHEMBL6696280 0.77 TP53 (0.49) SMN1; SMN2HTTTP53GAAALDH1A1
SCHEMBL2651526 0.75 ALDH1A1 (0.34) POLBSMN1; SMN2HTTCHRM3TP53
SCHEMBL1343417 0.75 SMN1; SMN2 (0.53) POLBOGASMN1; SMN2HTTTP53
SCHEMBL2649375 0.74 OGA (0.48) POLBOGASMN1; SMN2HTTTP53
SCHEMBL1343431 0.74 OGA (0.48) POLBOGASMN1; SMN2HTTTP53
SCHEMBL6697295 0.74 OGA (0.49) POLBOGASMN1; SMN2HTTTP53
SCHEMBL6697150 0.73 OGA (0.47) POLBOGASMN1; SMN2HTTTP53
SCHEMBL6696934 0.72 OGA (0.46) POLBOGASMN1; SMN2HTTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531815-A1 GLUCOKINASE ACTIVATORS NOVO NORDISK A/S (DK) 2005-05-25 EP disclosed
WO-2004002481-A1 ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS NOVO NORDISK A/S (DK) 2004-01-08 WO disclosed